Torrent Pharma reaffirmed its commitment to enhancing annual margins by 50 to 100 basis points, targeting an EBITDA margin around 32.5% for the fiscal year 2025. The company also expressed ...

Cycle Pharmaceuticals Limited (Cycle) announced today the launch of VENXXIVA (tiopronin) Delayed-Release Tablets, for the ...

O n Monday, Citi analyst increased the price target for Torrent Pharma (TRP:IN) to INR4,000, up from INR3,940, while reiterating a Buy rating on the company's shares. The revision follows the ...

Torrent Pharmaceuticals Limited, the flagship Company of the Torrent Group, is one of the leading pharmaceutical companies having presence in Indian and global markets. The Company is a dominant ...

With the expiration of Boehringer Ingelheim’s patent on Empagliflozin, several Indian pharmaceutical companies are set to ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Companies such as Cadila Healthcare, Alembic Pharmaceuticals, and Torrent Pharmaceuticals have reported lower sales from the US market in the first quarter ended June 30, 2021. Consolidated ...

Motilal Oswal recommended Neutral rating on Torrent Pharma with a target price of Rs 3410 in its research report dated January 25, 2025. Torrent Pharma Consolidated December 2024 Net Sales at Rs ...

Indian Pharmaceuticals Market has delivered marginally lower revenue at 7.5% year on year in February 2025, compared to 8.7% ...

Learn about Torrent Pharmaceuticals Limited in Mehsana, Gujarat.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location. If you own or ...

Torrent Pharmaceuticals Ltd share price was up by 2.26% from the previous closing price of ₹3,066.35. Who are peers of Torrent Pharmaceuticals Ltd? The peers of Torrent Pharmaceuticals Ltd are ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...